Baylor College of Medicine Opens Postdoctoral Role in Stem Cell and Leukemia Biology
Baylor College of Medicine is recruiting a Postdoctoral Associate in the Department of Molecular and Human Genetics for work centered on stem cell biology and cancer biology. The position sits in Houston and carries a stated salary range of $63,480 to $70,000, with a closing date of 5 Jan 2027. It is listed as a full-time, permanent postdoctoral research role requiring a PhD, with MD or PhD training accepted under the minimum qualifications.
The core scientific assignment is sharply defined: the successful candidate will help elucidate how blood-forming stem cells accrue mutations and move into a premalignant state in vivo. In practical terms, this places the work at the intersection of hematopoiesis, clonal evolution, and early leukemogenesis. A project like this matters because malignant transformation in the blood rarely appears all at once. It often begins with subtle genetic changes in hematopoietic stem cells, followed by altered cell behavior, expanding mutant clones, and eventually a cellular ecosystem that can support leukemia.
One sentence captures the biological stakes of the role: early mutational events in stem cells can determine whether normal blood production remains stable or tips toward disease.
Experimental Work at the Interface of Hematopoiesis and Malignancy
The job description calls for hands-on work across several experimental platforms. The postdoctoral associate will perform flow cytometry, bone marrow transplantation, histological analyses, and general molecular biological techniques to study leukemia. The duties also include genomics profiling and transcriptomics profiling, both of which are essential for mapping how mutant stem cells differ from their normal counterparts at the level of DNA, RNA, and cell-state behavior.
These methods are not interchangeable. Flow cytometry can separate stem and progenitor compartments with precision, allowing investigators to track cellular composition and phenotype. Bone marrow transplantation can test whether a mutant population has functional advantage in vivo, a key step when studying stem cell competition and malignant potential. Histology adds tissue architecture and spatial context, helping connect molecular changes to the marrow environment itself. Genomics and transcriptomics then extend the analysis deeper, revealing mutation patterns and transcriptional programs that may mark the earliest steps toward leukemic transformation.
The work therefore sits in a translationally important zone: basic mechanistic research designed to explain how disease begins, before overt leukemia is clinically apparent. That kind of inquiry can influence how hematologic malignancies are conceptualized long before any bedside intervention is possible.
What the Role Demands From a Postdoctoral Researcher
Baylor expects the postdoctoral associate to drive experiments designed to study either leukemia or hematopoietic stem cell biology, analyze and record the results, and work with the principal investigator to prepare a manuscript. The duties also include literature review, summarizing experimental findings, preparing draft manuscripts, and presenting results to the scientific community. Presentation slides for lab meetings and external scientific forums are part of the assignment as well.
The repetition in the posting around presentation and dissemination signals a conventional but demanding postdoctoral expectation: generate data, interpret it, and convert it into a publishable scientific narrative. For a candidate working in stem cell and leukemia research, that means the role is not only experimental. It requires the ability to structure results around a mechanistic hypothesis, place them in the context of prior literature, and communicate them with enough rigor to support publication.
The position does not require prior experience. Even so, the preferred qualifications make the scientific direction clear. Baylor favors candidates with MD/PhD or PhD training in cell biology, molecular biology, or related fields. Experience in stem cell biology and/or cancer biology is described as highly desirable, and candidates with strong bioinformatics or systems biology backgrounds are specifically encouraged to apply.
Why Bioinformatics Matters in Early Leukemia Research
A systems-level skill set is especially relevant in this area because early leukemic evolution is rarely explained by a single readout. Genomic alterations, transcriptional shifts, and changes in stem cell behavior often need to be interpreted together. Bioinformatics can help identify recurring pathways, distinguish driver patterns from background variation, and integrate datasets from flow cytometry, sequencing, and transplantation experiments into a coherent model of disease initiation.
For hematology researchers, that integration has real scientific value. Mutant hematopoietic stem cells may look modestly altered at first glance, yet those changes can carry disproportionate biological consequences over time. A capable postdoctoral scientist in this setting must be able to move between bench work and computational analysis without losing sight of the underlying disease question: how does a normal stem cell become the seed of a premalignant clone?
The role also reflects the structure of modern academic research careers. It is not a technical support post. It is a lead-researcher position within a laboratory environment, with direct responsibility for experimental execution, data interpretation, and manuscript preparation. The position is also listed under academia, indicates its place in a training-and-output model rather than a clinical service line.
A Research Appointment Built Around Leukemia Initiation
The scientific center of gravity here is the earliest phase of blood cancer development. By focusing on how stem cells acquire mutations in vivo, the project aims at a problem that is both biologically fundamental and clinically consequential. Premalignant states matter because they occupy the space between normal hematopoiesis and established leukemia, a space where clonal expansion may be measurable even before full malignant conversion.
That emphasis on initiation, not just progression, gives the position a distinctive profile. The postdoctoral associate will not simply be cataloging established disease. The work is meant to help explain how disease begins in the marrow compartment, where the balance between self-renewal and differentiation can shift under the influence of acquired mutations.
The advertisement closes with a standard equal opportunity statement, noting that Baylor College of Medicine is an Equal Opportunity/Affirmative Action/Equal Access Employer. For applicants, the practical takeaway is straightforward: this is a full-time postdoctoral research post in Houston, centered on stem cell mutation biology, leukemia modeling, and multi-platform experimental analysis, with a stated deadline in early 2027 and a salary band already defined. The remaining uncertainty lies in the specific project structure and data path, which will be determined inside the laboratory rather than by the posting itself.